Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

healthcare

Earnings blow for CSPC Pharma

Earnings blow for CSPC Pharma as the state drives a hard bargain

The generic drugs giant has warned of a 26% slide in annual profits after China’s national healthcare system imposed big price cuts on qualifying medicines   Key Takeaways: CSPC Pharma…
March 6, 2025
1093.HK

BRIEF: China Traditional Chinese Medicine’s profit tumbles in 2024

China Traditional Chinese Medicine Holdings Co. Ltd. (0570.HK) on Wednesday warned that it expects to report its profit for all of 2024 fell by 90% to 100%, while its adjusted…
January 16, 2025
0570.HK
Saint Bella filed for Hong Kong listing

Saint Bella births Hong Kong IPO, in race to nurture a postpartum empire

The company is feeding off growing Chinese demand for postpartum care, but could face headwinds from a slowing economy and plunging birthrates Key Takeaways: Saint Bella has filed to list…
January 13, 2025

BRIEF: Ping An Healthcare controlling shareholder makes share offer, says no plans for privatization

Online healthcare platform Ping An Healthcare (1833.HK) announced on Tuesday evening that its controlling shareholder, Ping An Insurance (2318.HK; 601318.SH), has offered to buy all of the company’s shares under…
January 8, 2025
1833.HK 2318.HK 601318.SHG

BRIEF: Concord Healthcare ties with Mayo Clinic to improve management

Medical services provider Concord Healthcare Group Co. Ltd. (2453.HK) said Thursday it has entered into an agreement for Mayo Foundation, operator of the Mayo Clinic, to provide it with consulting…
January 3, 2025
2453.HK
AIX looks like a good buy

INVESTOR VIEW: AIX is an underrated star in the AI insurance and health sectors

The company’s recent combination with BGM Group through an acquisition puts it in strong position to benefit from future integration of AI into the insurance business    By Rucha Gupda…
December 27, 2024
AIFU.US

BRIEF: Xunfei Healthcare to raise $75 million in Hong Kong IPO

Xunfei Healthcare Technology Co. Ltd. (2506.HK), the healthcare arm of artificial intelligence company iFlytek (002230.SZ), said it expects to raise about HK$580 million ($75 million) in its Hong Kong IPO. Xunfei…
December 19, 2024
2506.HK
Load more

Recent Articles

Earnings blow for CSPC Pharma
March 6, 2025

Earnings blow for CSPC Pharma as the state drives a hard bargain

1093.HK
January 16, 2025

BRIEF: China Traditional Chinese Medicine’s profit tumbles in 2024

0570.HK
January 13, 2025

Saint Bella births Hong Kong IPO, in race to nurture a postpartum empire

January 8, 2025

BRIEF: Ping An Healthcare controlling shareholder makes share offer, says no plans for privatization

1833.HK 2318.HK 601318.SHG
January 3, 2025

BRIEF: Concord Healthcare ties with Mayo Clinic to improve management

2453.HK
December 27, 2024

INVESTOR VIEW: AIX is an underrated star in the AI insurance and health sectors

AIFU.US
December 19, 2024

BRIEF: Xunfei Healthcare to raise $75 million in Hong Kong IPO

2506.HK

RELATED ARTICLES

  1. Hengrui Pharma
    December 19, 2024
    Hengrui Pharma accelerates bid for global brand status
    600276.SHG
  2. December 5, 2024
    Xuanzhu Biopharm set for spin-off in Hong Kong IPO
    0460.HK
  3. December 13, 2024
    Innogen Pharma jostles for a slice of the weight-loss market
  4. January 9, 2025
    Cancer drug maker Genfleet joins Hong Kong IPO influx
  5. February 6, 2025
    After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
    2696.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Premium Content
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2024 Bamboo Works. All rights reserved.